Collectionner le produit
Détails du produit
- ProductSizeAmountCellectra™ Human CD14 NanoSort Microbeads, Research grade2 mL Reconstitution BufferFor 10⁹ total cells
Product Show
This product is compatible with mainstream automated cell processing instruments and commercially available column-based (M/D/L) magnetic separation systems.
Product Description
Cellectra™ Human CD14 NanoSort Microbeads are 50 nm dextran-coated superparamagnetic iron oxide nanoparticles which the surface is conjugated with recombinant monoclonal antibodies specific to human CD14 (Isotype: mouse IgG1). They are especially designed for positive selection of CD14+ cells.
Cellectra™ Human CD14 NanoSort Microbeads are produced under sterile manufacturing conditions (ISO 5), and no animal- or human-derived components are used throughout the production process. It is produced under our rigorous quality control system that includes a comprehensive set of tests including sterility and endotoxin tests.Application
Cellectra™ Human CD14 NanoSort Microbeads are designed for the positive selection of monocytes and macrophages from fresh or frozen human peripheral blood mononuclear cells (PBMCs). CD14, a glycosylphosphatidylinositol (GPI)-anchored membrane protein, is predominantly expressed on the surface of human monocytes and macrophages. The magnetic nBeads are conjugated with monoclonal antibodies targeting human CD14 protein, enabling CD14+ cells to be labeled with the specific antibodies and magnetic particles, and separated using the separation columns and magnets.
Storage
This product is stable after storage at: 2-8°C for 36 months in lyophilized state; 2-8°C for 18 months under sterile conditions after reconstitution.
Please avoid repeated freeze-thaw cycles once reconstituion.
Sterility
Negative
Endotoxin
Less than 0.002 EU per μL by the LAL method / rFC method.
Mycoplasma
Negative
Important Note
This product is for research use only and not intended for therapeutic or in vivo diagnostic use.
Formulation
Please contact us for detailed information.
Contact us for customized product form or formulation.
ACRO Quality Management System
Les clients ont également consulté
Affichage des données
FACS Data
The purity of CD14+ cells isolated by Cellectra™ Human CD14 NanoSort Microbeads, Research grade (Cat. No. MBS-S001).
The CD14+ cells were isolated from human PBMCs using Cellectra™ Human CD14 NanoSort Microbeads, Research grade (Cat. No. MBS-S001). The isolated cells and non-isolated cells were respectively stained using PE anti-human CD14 antibody, and then analyzed by FCS Express 7 software.Protocol
Avis des utilisateurs Publier un commentaire
Progrès de frontière
Progrès du développement médicamenteux- Nom anglais：
Monocyte differentiation antigen CD14
- Catégorie：
- Nombre de médicaments répertoriés：
0 Détails
- Nombre de médicaments cliniques：
3 Détails
- Étape de développement la plus élevée：
Phase 2 Clinical
Contact Us
Drug Candidate Licensing
